New ICD-10-CM Codes in

619 codes were added to the 2021 ICD-10-CM code set, effective October 1, 2020.

Displaying codes 1-100 of 619:

  • A84.81 Powassan virus disease
  • A84.89 Other tick-borne viral encephalitis
  • B60.00 Babesiosis, unspecified
  • B60.01 Babesiosis due to Babesia microti
  • B60.02 Babesiosis due to Babesia duncani
  • B60.03 Babesiosis due to Babesia divergens
  • B60.09 Other babesiosis
  • D57.03 Hb-SS disease with cerebral vascular involvement
  • D57.09 Hb-SS disease with crisis with other specified complication
  • D57.213 Sickle-cell/Hb-C disease with cerebral vascular involvement
  • D57.218 Sickle-cell/Hb-C disease with crisis with other specified complication
  • D57.413 Sickle-cell thalassemia, unspecified, with cerebral vascular involvement
  • D57.418 Sickle-cell thalassemia, unspecified, with crisis with other specified complication
  • D57.42 Sickle-cell thalassemia beta zero without crisis
  • D57.43 Sickle-cell thalassemia beta zero with crisis
  • D57.431 Sickle-cell thalassemia beta zero with acute chest syndrome
  • D57.432 Sickle-cell thalassemia beta zero with splenic sequestration
  • D57.433 Sickle-cell thalassemia beta zero with cerebral vascular involvement
  • D57.438 Sickle-cell thalassemia beta zero with crisis with other specified complication
  • D57.439 Sickle-cell thalassemia beta zero with crisis, unspecified
  • D57.44 Sickle-cell thalassemia beta plus without crisis
  • D57.45 Sickle-cell thalassemia beta plus with crisis
  • D57.451 Sickle-cell thalassemia beta plus with acute chest syndrome
  • D57.452 Sickle-cell thalassemia beta plus with splenic sequestration
  • D57.453 Sickle-cell thalassemia beta plus with cerebral vascular involvement
  • D57.458 Sickle-cell thalassemia beta plus with crisis with other specified complication
  • D57.459 Sickle-cell thalassemia beta plus with crisis, unspecified
  • D57.813 Other sickle-cell disorders with cerebral vascular involvement
  • D57.818 Other sickle-cell disorders with crisis with other specified complication
  • D59.10 Autoimmune hemolytic anemia, unspecified
  • D59.11 Warm autoimmune hemolytic anemia
  • D59.12 Cold autoimmune hemolytic anemia
  • D59.13 Mixed type autoimmune hemolytic anemia
  • D59.19 Other autoimmune hemolytic anemia
  • D72.10 Eosinophilia, unspecified
  • D72.11 Hypereosinophilic syndrome [HES]
  • D72.110 Idiopathic hypereosinophilic syndrome [IHES]
  • D72.111 Lymphocytic Variant Hypereosinophilic Syndrome [LHES]
  • D72.118 Other hypereosinophilic syndrome
  • D72.119 Hypereosinophilic syndrome [HES], unspecified
  • D72.12 Drug rash with eosinophilia and systemic symptoms syndrome
  • D72.18 Eosinophilia in diseases classified elsewhere
  • D72.19 Other eosinophilia
  • D84.81 Immunodeficiency due to conditions classified elsewhere
  • D84.82 Immunodeficiency due to drugs and external causes
  • D84.821 Immunodeficiency due to drugs
  • D84.822 Immunodeficiency due to external causes
  • D84.89 Other immunodeficiencies
  • D89.83 Cytokine release syndrome
  • D89.831 Cytokine release syndrome, grade 1
  • D89.832 Cytokine release syndrome, grade 2
  • D89.833 Cytokine release syndrome, grade 3
  • D89.834 Cytokine release syndrome, grade 4
  • D89.835 Cytokine release syndrome, grade 5
  • D89.839 Cytokine release syndrome, grade unspecified
  • E70.81 Aromatic L-amino acid decarboxylase deficiency
  • E70.89 Other disorders of aromatic amino-acid metabolism
  • E74.81 Disorders of glucose transport, not elsewhere classified
  • E74.810 Glucose transporter protein type 1 deficiency
  • E74.818 Other disorders of glucose transport
  • E74.819 Disorders of glucose transport, unspecified
  • E74.89 Other specified disorders of carbohydrate metabolism
  • F10.13 Alcohol abuse, with withdrawal
  • F10.130 Alcohol abuse with withdrawal, uncomplicated
  • F10.131 Alcohol abuse with withdrawal delirium
  • F10.132 Alcohol abuse with withdrawal with perceptual disturbance
  • F10.139 Alcohol abuse with withdrawal, unspecified
  • F10.93 Alcohol use, unspecified with withdrawal
  • F10.930 Alcohol use, unspecified with withdrawal, uncomplicated
  • F10.931 Alcohol use, unspecified with withdrawal delirium
  • F10.932 Alcohol use, unspecified with withdrawal with perceptual disturbance
  • F10.939 Alcohol use, unspecified with withdrawal, unspecified
  • F11.13 Opioid abuse with withdrawal
  • F12.13 Cannabis abuse with withdrawal
  • F13.13 Sedative, hypnotic or anxiolytic abuse with withdrawal
  • F13.130 Sedative, hypnotic or anxiolytic abuse with withdrawal, uncomplicated
  • F13.131 Sedative, hypnotic or anxiolytic abuse with withdrawal delirium
  • F13.132 Sedative, hypnotic or anxiolytic abuse with withdrawal with perceptual disturbance
  • F13.139 Sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified
  • F14.13 Cocaine abuse, unspecified with withdrawal
  • F14.93 Cocaine use, unspecified with withdrawal
  • F15.13 Other stimulant abuse with withdrawal
  • F19.13 Other psychoactive substance abuse with withdrawal
  • F19.130 Other psychoactive substance abuse with withdrawal, uncomplicated
  • F19.131 Other psychoactive substance abuse with withdrawal delirium
  • F19.132 Other psychoactive substance abuse with withdrawal with perceptual disturbance
  • F19.139 Other psychoactive substance abuse with withdrawal, unspecified
  • G11.10 Early-onset cerebellar ataxia, unspecified
  • G11.11 Friedreich ataxia
  • G11.19 Other early-onset cerebellar ataxia
  • G40.42 Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
  • G40.83 Dravet syndrome
  • G40.833 Dravet syndrome, intractable, with status epilepticus
  • G40.834 Dravet syndrome, intractable, without status epilepticus
  • G71.20 Congenital myopathy, unspecifed
  • G71.21 Nemaline myopathy
  • G71.22 Centronuclear myopathy
  • G71.220 X-linked myotubular myopathy
  • G71.228 Other centronuclear myopathy
  • G71.29 Other congenital myopathy